Stoke Therapeutics, Inc. STOK

Set alert

27.45 USD +0.46 (+1.70%)

At closeNov 4, 2026, 5:03 PM EST

27.45 0.00 0.00%

After hours · Nov 4, 5:03 PM ET

26.60 Day range 27.75

20.32 52-week range 40.22

Held by insiders 3.67%

Held by institutions 124.74%

Float held by institutions 129.48%

Institutions 272

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	9.11%	5,877,357	161.33M	Jun 29, 2026
RTW Investments LP	8.72%	5,623,525	154.37M	Jun 29, 2026
FMR, LLC	8.23%	5,313,100	145.84M	Jun 29, 2026
Lynx1 Capital Management Lp	6.26%	4,038,404	110.85M	Jun 29, 2026
Redmile Group, LLC	6.12%	3,945,920	108.32M	Jun 29, 2026
Wellington Management Group, LLP	5.45%	3,519,301	96.60M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund	3.50%	2,260,550	62.05M	Jul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	2.92%	1,884,647	51.73M	Jun 29, 2026
Fidelity Select Portfolios-Select Biotechnology Portfolio	2.30%	1,482,681	40.70M	Aug 30, 2026
iShares Trust-iShares Russell 2000 ETF	2.21%	1,426,549	39.16M	Sep 29, 2026
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.03%	1,311,567	36.00M	Sep 29, 2026
T. Rowe Price New Horizons Fund, Inc.	1.13%	729,201	20.02M	Jun 29, 2026

STOK insiders
Insider	Relation	Latest transaction	Date	Shares held
ALLAN JONATHAN	General Counsel	Sale	Aug 17, 2026	21,225
HOITT JASON	Officer	Sale	Mar 17, 2026	10,276
KAYE EDWARD M	Director	Sale	Aug 17, 2026	124,557
KRAINER ADRIAN R	Director	Sale	Mar 9, 2026	283,302
LEGGETT THOMAS	Chief Financial Officer	Sale	Mar 17, 2026	10,172
LEVIN ARTHUR A.	Director	Sale	Mar 12, 2026	22,216

Held by funds